Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Fixed-dose rate gemcitabine plus docetaxel as second-line... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study
0
Authors
Martee Hensley
5 more
Martee Hensley
•
John Blessing
3 more
•
Howard Homesley
Published
April 21, 2008
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Gynecologic Oncology
Topics
Medicine
Cancer Oncology
Internal Medicine
Urology
Surgery
Show all topics
DOI
10.1016/j.ygyno.2008.02.024
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Gynecologic Oncology
Topics
Medicine
Cancer Oncology
Internal Medicine
Urology
Surgery
Show all topics
DOI
10.1016/j.ygyno.2008.02.024
Other Formats
PDF
